Identification of the α2 chain of interleukin‐13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient‐derived xenograft models

BACKGROUND: Several treatment strategies use upfront chemotherapy or androgen receptor axis‐targeting therapies for metastatic prostate cancer. However, there are no useful biomarkers for selecting appropriate patients who urgently require these treatments. METHODS: Novel patient‐derived xenograft (...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagai, Takahiro, Terada, Naoki, Fujii, Masato, Nagata, Yasuhisa, Nakahara, Kozue, Mukai, Shoichiro, Okasho, Kosuke, Kamiyama, Yuki, Akamatsu, Shusuke, Kobayashi, Takashi, Iida, Kei, Denawa, Masatsugu, Hagiwara, Masatoshi, Inoue, Takahiro, Ogawa, Osamu, Kamoto, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939991/
https://www.ncbi.nlm.nih.gov/pubmed/36806727
http://dx.doi.org/10.1002/cnr2.1701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939991/
https://www.ncbi.nlm.nih.gov/pubmed/36806727
http://dx.doi.org/10.1002/cnr2.1701

Ejemplares similares